231 related articles for article (PubMed ID: 28666544)
21. Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges.
Wen MM; El-Salamouni NS; El-Refaie WM; Hazzah HA; Ali MM; Tosi G; Farid RM; Blanco-Prieto MJ; Billa N; Hanafy AS
J Control Release; 2017 Jan; 245():95-107. PubMed ID: 27889394
[TBL] [Abstract][Full Text] [Related]
22. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
Viola KL; Klein WL
Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
[TBL] [Abstract][Full Text] [Related]
23. En route to early diagnosis of Alzheimer's disease--are we there yet?
Fradinger EA; Bitan G
Trends Biotechnol; 2005 Nov; 23(11):531-3. PubMed ID: 16165236
[TBL] [Abstract][Full Text] [Related]
24. An Overview on Global Trends in Nanotechnological Approaches for Alzheimer Therapy.
Ashraf GM; Tabrez S; Jabir NR; Firoz CK; Ahmad S; Hassan I; Alexiou A; Kamal MA
Curr Drug Metab; 2015; 16(8):719-27. PubMed ID: 26560324
[TBL] [Abstract][Full Text] [Related]
25. The future of Alzheimer's disease: the next 10 years.
Hampel H; Prvulovic D; Teipel S; Jessen F; Luckhaus C; Frölich L; Riepe MW; Dodel R; Leyhe T; Bertram L; Hoffmann W; Faltraco F;
Prog Neurobiol; 2011 Dec; 95(4):718-28. PubMed ID: 22137045
[TBL] [Abstract][Full Text] [Related]
26. Bionanotechnologies for treatment and diagnosis of Alzheimer's disease.
Moghimi SM
Nanomedicine; 2011 Oct; 7(5):515-8. PubMed ID: 21616169
[No Abstract] [Full Text] [Related]
27. Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease.
Le Droumaguet B; Nicolas J; Brambilla D; Mura S; Maksimenko A; De Kimpe L; Salvati E; Zona C; Airoldi C; Canovi M; Gobbi M; Magali N; La Ferla B; Nicotra F; Scheper W; Flores O; Masserini M; Andrieux K; Couvreur P
ACS Nano; 2012 Jul; 6(7):5866-79. PubMed ID: 22725248
[TBL] [Abstract][Full Text] [Related]
28. Application of nanotechnology in biomedicine.
Navalakhe RM; Nandedkar TD
Indian J Exp Biol; 2007 Feb; 45(2):160-5. PubMed ID: 17375555
[TBL] [Abstract][Full Text] [Related]
29. Nanotechnology: Future of Oncotherapy.
Gharpure KM; Wu SY; Li C; Lopez-Berestein G; Sood AK
Clin Cancer Res; 2015 Jul; 21(14):3121-30. PubMed ID: 26180057
[TBL] [Abstract][Full Text] [Related]
30. Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity.
Hampel H; Mitchell A; Blennow K; Frank RA; Brettschneider S; Weller L; Möller HJ
J Neural Transm (Vienna); 2004 Mar; 111(3):247-72. PubMed ID: 14991453
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and management of Alzheimer's disease--an update.
Srinivas P
Med J Malaysia; 1999 Dec; 54(4):541-9; quiz 550. PubMed ID: 11072482
[TBL] [Abstract][Full Text] [Related]
32. Advances in imaging-genetic relationships for Alzheimer's disease: clinical implications.
Bagnoli S; Piaceri I; Sorbi S; Nacmias B
Neurodegener Dis Manag; 2014; 4(1):73-81. PubMed ID: 24640981
[TBL] [Abstract][Full Text] [Related]
33. Nanoformulated alpha-mangostin ameliorates Alzheimer's disease neuropathology by elevating LDLR expression and accelerating amyloid-beta clearance.
Yao L; Gu X; Song Q; Wang X; Huang M; Hu M; Hou L; Kang T; Chen J; Chen H; Gao X
J Control Release; 2016 Mar; 226():1-14. PubMed ID: 26836197
[TBL] [Abstract][Full Text] [Related]
34. A review on advances of treatment modalities for Alzheimer's disease.
Se Thoe E; Fauzi A; Tang YQ; Chamyuang S; Chia AYY
Life Sci; 2021 Jul; 276():119129. PubMed ID: 33515559
[TBL] [Abstract][Full Text] [Related]
35. Nanomedicine as a promising approach for the treatment and diagnosis of brain diseases: the example of Alzheimer's disease.
Andrieux K; Couvreur P
Ann Pharm Fr; 2013 Jul; 71(4):225-33. PubMed ID: 23835020
[TBL] [Abstract][Full Text] [Related]
36. The biomarker and therapeutic potential of miRNA in Alzheimer's disease.
Bekris LM; Leverenz JB
Neurodegener Dis Manag; 2015; 5(1):61-74. PubMed ID: 25711455
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society.
Small GW; Rabins PV; Barry PP; Buckholtz NS; DeKosky ST; Ferris SH; Finkel SI; Gwyther LP; Khachaturian ZS; Lebowitz BD; McRae TD; Morris JC; Oakley F; Schneider LS; Streim JE; Sunderland T; Teri LA; Tune LE
JAMA; 1997 Oct 22-29; 278(16):1363-71. PubMed ID: 9343469
[TBL] [Abstract][Full Text] [Related]
38. Nanotherapeutics for Alzheimer's disease (AD): Past, present and future.
Fazil M; Shadab ; Baboota S; Sahni JK; Ali J
J Drug Target; 2012 Feb; 20(2):97-113. PubMed ID: 22023651
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory Processes in Alzheimer's Disease-Pathomechanism, Diagnosis and Treatment: A Review.
Twarowski B; Herbet M
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047492
[TBL] [Abstract][Full Text] [Related]
40. Non-conventional compounds with potential therapeutic effects against Alzheimer's disease.
de Castro AA; Soares FV; Pereira AF; Polisel DA; Caetano MS; Leal DHS; da Cunha EFF; Nepovimova E; Kuca K; Ramalho TC
Expert Rev Neurother; 2019 May; 19(5):375-395. PubMed ID: 30999771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
